Economic evaluation of the national immunization program of rotavirus vaccination for children in Korea

Hye Young Kang, Ki Hwan Kim, Ji Hong Kim, Hwang Min Kim, Jinkyung Kim, Mi Sun Kim, Antoine C. El Khoury, Dong Soo Kim

Research output: Contribution to journalArticlepeer-review

13 Citations (Scopus)


The authors assessed the cost-effectiveness of rotavirus vaccination to develop an evidence-based national immunization program in Korea. A Markov model was constructed to compare the costs and clinical outcomes of vaccination versus no vaccination. The birth cohort of 493189 infants in 2007 was followed until the age of 5 years. Korea-specific data for epidemiological characteristics and economic burden of rotavirus diarrhea were used for the modeled estimation. Efficacy of RotaTeq® was based on a recent clinical trial. Rotavirus vaccination would prevent 181238 symptomatic cases (reduction rate = 63.2%) over 5 years after birth. From the societal perspective, at a vaccination cost of 100000 Korean won (KW; 1 US$ ≈ 1200 KW) per dose, universal vaccination would cost 375 620 KW per case averted. The breakeven price of vaccine was 56061 KW. Rotavirus vaccination would reduce the burden of the disease substantially and be a cost-effective strategy to prevent rotavirus diarrhea in Korea.

Original languageEnglish
Pages (from-to)145-158
Number of pages14
JournalAsia-Pacific Journal of Public Health
Issue number2
Publication statusPublished - 2013 Mar

Bibliographical note

Funding Information:
This study was supported by an unrestricted grant from Merck & Co, Inc.

All Science Journal Classification (ASJC) codes

  • Public Health, Environmental and Occupational Health


Dive into the research topics of 'Economic evaluation of the national immunization program of rotavirus vaccination for children in Korea'. Together they form a unique fingerprint.

Cite this